Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.
作者信息
Tisdale John F, Pierciey Francis J, Bonner Melissa, Thompson Alexis A, Krishnamurti Lakshmanan, Mapara Markus Y, Kwiatkowski Janet L, Shestopalov Ilya, Ribeil Jean-Antoine, Huang Wenmei, Asmal Mohammed, Kanter Julie, Walters Mark C
机构信息
Cellular and Molecular Therapeutics Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
bluebird bio, Cambridge, Massachusetts, USA.
出版信息
Am J Hematol. 2020 Sep;95(9):E239-E242. doi: 10.1002/ajh.25867. Epub 2020 Jun 3.
PMID:32401372
Abstract
摘要
Zotero 插件